2021 Healthcare Provider Side effects 
PM360
JUNE 29, 2022
Despite a slew of prescription options and widespread advertising pushes, most patients are sticking with over-the-counter (OTC) remedies rather than trying new preventive medications, according to Phreesia Life Sciences’ survey results collected from more than 4,000 patients checking in for their doctors’ appointments in July 2021.
Pharmaceutical Technology
JULY 20, 2022
Prescribing it] requires knowledge of a patient’s medical history, as well as clinical monitoring for side effects and follow-up care to determine whether a patient is improving—requirements far beyond a pharmacist’s scope and training,” as per a statement by AMA president Jack Resneck.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
LEVO Health
JUNE 14, 2024
Here, we explore some of the top use cases where AI is improving the patient experience and engagement, showcasing how healthcare organizations can leverage this technology to meet their patients’ evolving needs. Healthcare Workforce Management AI can also optimize workforce management in healthcare settings.
Pharmaceutical Technology
NOVEMBER 30, 2022
In the US, obesity care is estimated at to cost $147 billion in healthcare spending annually. In the past, obesity medications were often dismissed due to insufficient efficacy data and the fact that they were associated with a high occurrence of side effects. Novo Nordisk is another company leading the charge in this field.
Pharma Marketing Network
MAY 3, 2023
Pharmaceutical marketing is a critical aspect of the industry, as it helps in spreading awareness about the benefits and potential side effects of different drugs. In recent years, digital marketing has become an increasingly important tool for pharmaceutical companies to reach patients and healthcare providers.
Pharmaceutical Technology
NOVEMBER 30, 2022
In the US, obesity care is estimated at to cost $147 billion in healthcare spending annually. In the past, obesity medications were often dismissed due to insufficient efficacy data and the fact that they were associated with a high occurrence of side effects. Novo Nordisk is another company leading the charge in this field.
European Pharmaceutical Review
AUGUST 30, 2022
Nasal delivery is non-invasive and provides a more targeted delivery than the systemic injectable approach, potentially offering a quicker response and reduced side effects. million by 2029, up from $122.287 million in 2021. These innovations can go a long way towards making nasal a viable route for vaccine development.
Expert insights. Personalized for you.
98 
Let's personalize your content